Press release
A Stupendous CAGR Of 13% Between 2020 to 2030 To Be Clocked By The Atrial Fibrillation Devices Market
The Atrial Fibrillation Devices Market will witness a CAGR of 13%, reaching Expand Almost 4X between 2020 to 2030. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
Interventional electrophysiology devices have already had a significant impact on patients suffering from cardiac arrhythmias, and are being increasingly adopted as a permanent treatment option for atrial fibrillation. Procedures such as radiofrequency ablation, cryoablation, and cox-maze are well performed in today’s practice.
Planning Forward? Access Sample Of Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.co/samples/31531
Recent studies have found cryoablation to be more effective than medical management, and it is widely used in medical surgical practice. The overall market is primarily driven by the growing prevalence of atrial fibrillation amongst the geriatric as well as adult population, and the adoption of minimally-invasive techniques for the permanent treatment of atrial fibrillation.
Moreover, the use of innovative techniques, advancements in technology, and favorable reimbursement scenario are some other factors responsible for propelling the growth of the atrial fibrillation devices market.
Companies covered in Atrial Fibrillation Devices Market Report
Biosensense Webster, Inc. (Johnson & Johnson)
Abbott Laboratories
Medtronic Plc
Boston Scientific Corporation
AtriCure, Inc.
Japan Lifeline Co.
MicroPort Scientific Corporation
Biomerics
CathRx
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Atrial Fibrillation Devices Market? https://www.persistencemarketresearch.co/methodology/31531
As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).
Key Takeaways from Atrial Fibrillation Devices Market Study
The diagnostics segment, by product, is expected to gain maximum revenue share over the forecast period. The therapeutic segment is anticipated to increase at a CAGR of 15% over 2020–2030, to reach US$ 8.3 Bn by 2030.
According to PMR data collected from electrophysiologists in various regions, radiofrequency catheter ablation is the procedure of choice due to the high success rate, while cryoablation is the second preference for atrial fibrillation catheter ablation.
By technology, the radiofrequency and cryoablation segments, collectively held more than70% market share in terms of revenue in 2019.
Among all end users, hospitals is the leading segment, which is followed by cardiac catheterization laboratories. The hospitals segment is anticipated to expand at a CAGR of 14%over the forecast period.
North America and Europe, collectively held more than 70%revenue share in 2019, while South Asia is expected to show greater growth potential over the forecast period.
With the ongoing Covid-19pandemic wreaking havoc across the world, other non-emergency treatments have been deprioritized. As such in the near-term, the growth of the atrial fibrillation devices market will be slower than the average for the decade ahead.
“New product approvals and launches of ablation catheters along with increasing demand for minimally-invasive procedures offering increased longevity and safety profiles are driving the growth of the global atrial fibrillation devices market,” says a PMR analyst.
Planning To Introduce An Offbeat Product/Technology In The Atrial Fibrillation Devices Market? Go To “Purchase Now” To Have Our Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.com/checkout/31531
New Product Launches – Key Strategic Focus of Market Players
Product approvals by the FDA for new AF devices are responsible for intense competition among market players. Numerous organizations are focusing on new product launches for electrophysiology, especially for atrial fibrillation.
For instance, in August 2016, Biosense Webster, Inc., a world leader in the treatment and diagnosis of heart arrhythmias, announced the launch of THERMOCOOL SMARTTOUCH SF catheters with contact force technology and a porous tip designed to optimize the treatment of atrial fibrillation.
Also, in January 2019, Abbott announced FDA approval for the TactiCath Contact Force Ablation Catheter. These winning strategies by leading players in the atrial fibrillation devices market are also being followed by regional and local players.
Atrial Fibrillation Devices Market: Competition Landscape
The global market is set to broaden its scope during the forecast period, stimulated by the rising prevalence of AF, worldwide. In addition, a favorable reimbursement scenario and increasing demand for minimally-invasive procedures have augmented the sales of atrial fibrillation devices.
The market is dominated by 4 major manufacturers – Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, and Boston Scientific Corporation, with a revenue share of over 70% in 2019. These major manufacturers are focusing on manufacturing electrophysiology devices used specifically for atrial fibrillation procedure, such as ablation devices, intracardiac echocardiography catheters, and left atrial appendage (LAA) management devices.
Key market players covered by PMR include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, ArtiCure, Inc., Japan Lifeline Co., Biomerics, MicroPort Corporation, and CathRx, who are consolidating their position through mergers, acquisitions, and new product launches.
Want more insights?
PMR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global atrial fibrillation devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights on the atrial fibrillation devices market on basis of product (diagnostics – conventional EP catheters, mapping catheters, CS catheters, and ICE catheters) and therapeutics – EP ablation, maze surgery, and LAA management devices), technology (radiofrequency, crythotherapy, ultrasound, and others), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories), across seven major regions.
Access Related Reports-
Pressure Relief Devices Market @ https://www.prnewswire.com/news-releases/pressure-relief-devices-market-will-reach-at-a-cagr-of-5-5-from-2018-to-2026—persistence-market-research-300851493.html
'PMR' Related Reports-
Electrophysiology Ablation Market: https://www.persistencemarketresearch.com/market-research/electrophysiology-ablation-market.asp
Interventional Pulmonology Market: https://www.persistencemarketresearch.com/market-research/interventional-pulmonology-market.asp
Heart Valve Repair Replacement Market: https://www.persistencemarketresearch.com/market-research/heart-valve-repair-replacement-market.asp
Angiography Catheters Market: https://www.persistencemarketresearch.com/market-research/angiography-catheters-market.asp
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Interventional electrophysiology devices have already had a significant impact on patients suffering from cardiac arrhythmias, and are being increasingly adopted as a permanent treatment option for atrial fibrillation. Procedures such as radiofrequency ablation, cryoablation, and cox-maze are well performed in today’s practice.
Planning Forward? Access Sample Of Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.co/samples/31531
Recent studies have found cryoablation to be more effective than medical management, and it is widely used in medical surgical practice. The overall market is primarily driven by the growing prevalence of atrial fibrillation amongst the geriatric as well as adult population, and the adoption of minimally-invasive techniques for the permanent treatment of atrial fibrillation.
Moreover, the use of innovative techniques, advancements in technology, and favorable reimbursement scenario are some other factors responsible for propelling the growth of the atrial fibrillation devices market.
Companies covered in Atrial Fibrillation Devices Market Report
Biosensense Webster, Inc. (Johnson & Johnson)
Abbott Laboratories
Medtronic Plc
Boston Scientific Corporation
AtriCure, Inc.
Japan Lifeline Co.
MicroPort Scientific Corporation
Biomerics
CathRx
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Atrial Fibrillation Devices Market? https://www.persistencemarketresearch.co/methodology/31531
As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).
Key Takeaways from Atrial Fibrillation Devices Market Study
The diagnostics segment, by product, is expected to gain maximum revenue share over the forecast period. The therapeutic segment is anticipated to increase at a CAGR of 15% over 2020–2030, to reach US$ 8.3 Bn by 2030.
According to PMR data collected from electrophysiologists in various regions, radiofrequency catheter ablation is the procedure of choice due to the high success rate, while cryoablation is the second preference for atrial fibrillation catheter ablation.
By technology, the radiofrequency and cryoablation segments, collectively held more than70% market share in terms of revenue in 2019.
Among all end users, hospitals is the leading segment, which is followed by cardiac catheterization laboratories. The hospitals segment is anticipated to expand at a CAGR of 14%over the forecast period.
North America and Europe, collectively held more than 70%revenue share in 2019, while South Asia is expected to show greater growth potential over the forecast period.
With the ongoing Covid-19pandemic wreaking havoc across the world, other non-emergency treatments have been deprioritized. As such in the near-term, the growth of the atrial fibrillation devices market will be slower than the average for the decade ahead.
“New product approvals and launches of ablation catheters along with increasing demand for minimally-invasive procedures offering increased longevity and safety profiles are driving the growth of the global atrial fibrillation devices market,” says a PMR analyst.
Planning To Introduce An Offbeat Product/Technology In The Atrial Fibrillation Devices Market? Go To “Purchase Now” To Have Our Atrial Fibrillation Devices Market Report! https://www.persistencemarketresearch.com/checkout/31531
New Product Launches – Key Strategic Focus of Market Players
Product approvals by the FDA for new AF devices are responsible for intense competition among market players. Numerous organizations are focusing on new product launches for electrophysiology, especially for atrial fibrillation.
For instance, in August 2016, Biosense Webster, Inc., a world leader in the treatment and diagnosis of heart arrhythmias, announced the launch of THERMOCOOL SMARTTOUCH SF catheters with contact force technology and a porous tip designed to optimize the treatment of atrial fibrillation.
Also, in January 2019, Abbott announced FDA approval for the TactiCath Contact Force Ablation Catheter. These winning strategies by leading players in the atrial fibrillation devices market are also being followed by regional and local players.
Atrial Fibrillation Devices Market: Competition Landscape
The global market is set to broaden its scope during the forecast period, stimulated by the rising prevalence of AF, worldwide. In addition, a favorable reimbursement scenario and increasing demand for minimally-invasive procedures have augmented the sales of atrial fibrillation devices.
The market is dominated by 4 major manufacturers – Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, and Boston Scientific Corporation, with a revenue share of over 70% in 2019. These major manufacturers are focusing on manufacturing electrophysiology devices used specifically for atrial fibrillation procedure, such as ablation devices, intracardiac echocardiography catheters, and left atrial appendage (LAA) management devices.
Key market players covered by PMR include Biosense Webster, Inc. (Johnson & Johnson), Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, ArtiCure, Inc., Japan Lifeline Co., Biomerics, MicroPort Corporation, and CathRx, who are consolidating their position through mergers, acquisitions, and new product launches.
Want more insights?
PMR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global atrial fibrillation devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights on the atrial fibrillation devices market on basis of product (diagnostics – conventional EP catheters, mapping catheters, CS catheters, and ICE catheters) and therapeutics – EP ablation, maze surgery, and LAA management devices), technology (radiofrequency, crythotherapy, ultrasound, and others), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories), across seven major regions.
Access Related Reports-
Pressure Relief Devices Market @ https://www.prnewswire.com/news-releases/pressure-relief-devices-market-will-reach-at-a-cagr-of-5-5-from-2018-to-2026—persistence-market-research-300851493.html
'PMR' Related Reports-
Electrophysiology Ablation Market: https://www.persistencemarketresearch.com/market-research/electrophysiology-ablation-market.asp
Interventional Pulmonology Market: https://www.persistencemarketresearch.com/market-research/interventional-pulmonology-market.asp
Heart Valve Repair Replacement Market: https://www.persistencemarketresearch.com/market-research/heart-valve-repair-replacement-market.asp
Angiography Catheters Market: https://www.persistencemarketresearch.com/market-research/angiography-catheters-market.asp
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
